Search
for
Sort by
Research 271–300 of 1000+
- Ursolic acid, a pentacyclic triterpene from Ochrosia elliptica Labill leaves and its role in the management of polycystic ovary syndrome (PCOS)
- Development of novel wound dressing based on elastin-like recombinamers for skin regeneration
- Sex hormones and sarcopenia in older persons
- Lupus erythematosus: systemic and cutaneous manifestations
- Oral medications for central serous chorioretinopathy: a literature review
- Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies
- Longitudinal clinical course, treatment outcomes, and relapse patterns in alopecia areata: a prospective cohort study
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Guidelines for the Use of Acitretin in Psoriasis
- The Evaluation and Management of Hirsutism
- Episodic Neuropathic-Like Musculoskeletal Pain Associated With Ritlecitinib Therapy in Alopecia Universalis: A Case Report
- The Polycystic Ovary Syndrome - Challenges and Opportunities in Adolescent Medicine
- Cutaneous signals of immune system disease
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Stress-Induced Deoxycorticosterone-Derived Neurosteroids Modulate GABA<sub>A</sub>Receptor Function and Seizure Susceptibility
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Sex differences in the hypothalamic–pituitary–adrenal axis’ response to stress: an important role for gonadal hormones
- COVID-19 and Sex Differences
- Endocrinology of Transgender Medicine
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Safety of testosterone treatment in postmenopausal women
- Endocrine-skin interactions
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Body composition changes and inhibition of fat development in vivo implicates androgen in regulation of stem cell lineage allocation
- Pharmacologic Therapy of Polycystic Ovary Syndrome
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Applications of steroid drugs entrapped in cyclodextrins
- Polycystic ovary syndrome and the differential diagnosis of hyperandrogenism